MyAverix Finance
F · Healthcare
KODIAK SCIENCES DL-0001 (K27)
Biotechnology
KODIAK SCIENCES DL-0001 (K27) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.13B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for K27
KODIAK SCIENCES DL-0001 (K27) — FAQ
What is KODIAK SCIENCES DL-0001's market cap?
KODIAK SCIENCES DL-0001 (K27) has a reported market cap of $2.13B (data as of 2026-03-29).
What is K27's P/E ratio?
The price-to-earnings (P/E) ratio for KODIAK SCIENCES DL-0001 (K27) is 18.00 (data as of 2026-03-29).
Does KODIAK SCIENCES DL-0001 pay a dividend?
Dividend yield is not available in the current snapshot for KODIAK SCIENCES DL-0001 (K27). Check the MyAverix Finance app for the latest dividend data.
What sector is KODIAK SCIENCES DL-0001 in?
KODIAK SCIENCES DL-0001 (K27) is classified in the Healthcare sector (Biotechnology industry).
What exchange is K27 listed on?
K27 is listed on F.
What is KODIAK SCIENCES DL-0001's net margin?
KODIAK SCIENCES DL-0001 (K27) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.